GDUFA IV: US FDA Worries About Revenue Shortfalls, Industry Does Not

The FDA warned industry about the consequences of continued under-collection of GDUFA fee revenue. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from User Fees

More from United States